(VIANEWS) – Shares of Viking Therapeutics (NASDAQ Composite: VKTX) slid 6.61% to $4.10 at 07:55 EST on Thursday, after two consecutive sessions in a row of losses. NASDAQ Composite is jumping 0.05% to $14,942.83, after three sequential sessions in a row of gains. This seems, so far, a somewhat up trend exchanging session today.
Viking Therapeutics’s last close was $4.10, 59.37% under its 52-week high of $10.09.
Today’s last reported volume for Viking Therapeutics is 1108730 which is 45.01% above its average volume of 764539.
The company’s growth estimates for the ongoing quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.18%, a negative 0.47%, and a positive 2.76%, respectively.
Viking Therapeutics’s highest amplitude of average volatility was 3.42% (last week), 3.17% (last month), and 2.76% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be overbought (>=80).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $4.10 at 07:55 EST, way below its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s value is way below its 50-day moving average of $5.82 and way under its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).